Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998
- PMID: 12232845
- DOI: 10.1086/343862
Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998
Abstract
To understand recent temporal trends in acquired immunodeficiency syndrome (AIDS) mortality in the era of highly active antiretroviral therapy (HAART), trends in causes of death among persons with AIDS in San Francisco who died between 1994 and 1998 were analyzed. Among 5234 deaths, the mortality rate for human immunodeficiency virus (HIV)-related or AIDS-related deaths declined after 1995 (P<.01), whereas the mortality rate for non-HIV- or non-AIDS-related deaths remained stable. The proportion of deaths of persons with AIDS associated with septicemia, non-AIDS-defining malignancy, chronic liver disease, viral hepatitis, overdose, obstructive lung disease, coronary artery disease, and pancreatitis increased (P<.05). The standardized mortality ratio was high for these causes in both pre- and post-HAART periods, except for pancreatitis, a possible complication of HAART, which demonstrated an increasing standardized mortality ratio trend after 1996. With increasing AIDS survival, prevention of chronic diseases, assessment of long-term toxicity from HAART, and surveillance for additional causes of mortality will become increasingly important.
Similar articles
-
Changes in causes of death among persons with AIDS: San Francisco, California, 1996-2011.AIDS Patient Care STDS. 2014 Oct;28(10):517-23. doi: 10.1089/apc.2014.0079. AIDS Patient Care STDS. 2014. PMID: 25275657
-
Evolving trends revealed by autopsies of patients with the acquired immunodeficiency syndrome. 565 autopsies in adults with the acquired immunodeficiency syndrome, Los Angeles, Calif, 1982-1993 [corrected].Arch Pathol Lab Med. 1994 Sep;118(9):884-90. Arch Pathol Lab Med. 1994. PMID: 8080357
-
[Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].Parassitologia. 2004 Jun;46(1-2):89-93. Parassitologia. 2004. PMID: 15305694 Review. Italian.
-
Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.Cancer. 2004 Jul 15;101(2):317-24. doi: 10.1002/cncr.20354. Cancer. 2004. PMID: 15241829
-
Non-AIDS-defining cancers: should antiretroviral therapy be initiated earlier?AIDS Read. 2008 Jan;18(1):18-20, 26-32. AIDS Read. 2008. PMID: 18240449 Review.
Cited by
-
Interactions between antiretrovirals and antineoplastic drug therapy.Clin Pharmacokinet. 2005;44(2):111-45. doi: 10.2165/00003088-200544020-00001. Clin Pharmacokinet. 2005. PMID: 15656694 Review.
-
Asthma diagnosis and airway bronchodilator response in HIV-infected patients.J Allergy Clin Immunol. 2012 Mar;129(3):708-714.e8. doi: 10.1016/j.jaci.2011.11.015. Epub 2011 Dec 15. J Allergy Clin Immunol. 2012. PMID: 22177327 Free PMC article.
-
Alterations in Oral Microbiota in HIV Are Related to Decreased Pulmonary Function.Am J Respir Crit Care Med. 2020 Feb 15;201(4):445-457. doi: 10.1164/rccm.201905-1016OC. Am J Respir Crit Care Med. 2020. PMID: 31682463 Free PMC article.
-
Decreased Lung Function and All-Cause Mortality in HIV-infected Individuals.Ann Am Thorac Soc. 2018 Feb;15(2):192-199. doi: 10.1513/AnnalsATS.201606-492OC. Ann Am Thorac Soc. 2018. PMID: 29313714 Free PMC article. Clinical Trial.
-
Trimethoprim-sulfamethoxazole treatment does not reverse obstructive pulmonary changes in pneumocystis-colonized nonhuman primates with SHIV infection.J Acquir Immune Defic Syndr. 2014 Apr 1;65(4):381-9. doi: 10.1097/QAI.0000000000000007. J Acquir Immune Defic Syndr. 2014. PMID: 24121760 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
